Case managers and medical directors need to have wide-ranging knowledge about how solid tumors are managed so that they can help patients with solid tumors coordinate their care among different specialists (e.g., diagnostic radiology, medical oncology, palliative care).

Patients with relapsed or refractory (R/R) cancers have a poor prognosis and limited treatment options.

Join Mary S. Mably, RPh, BCOP, from University of Wisconsin Carbone Cancer Center for this webinar in the 2018 NCCN Pharmacy Update Series on the topic Role of Biosimilar Agents in Myeloid Growth Factor Therapy.

Join Katie Gauen, PharmD, from Robert H. Lurie Comprehensive Cancer Center of Northwestern University for this webinar in the 2018 NCCN Pharmacy Update Series on the topic of Safe Handling of Chemotherapy.

Novel Targeted Therapies and Immunotherapies for Metastatic Non-small Cell Lung Cancer (NSCLC)

As multidisciplinary cancer care becomes increasingly common, it is important for all members of the care team to understand the basics of cancer biology, diagnosis, and treatment to best care for their patients.

The goal of this activity is to ensure that members of the multidisciplinary oncology care team, including physicians, nurses, pharmacists and other relevant health care professionals, have the knowledge and skills necessary to apply the new standards of care for patients with an acute leukemia.

The goal of this activity is to ensure that members of the multidisciplinary oncology care team, including physicians, nurses, pharmacists and other relevant health care professionals, have the knowledge and skills necessary to apply the new standards of care for patients with an acute leukemia.

The goal of this activity is to ensure that members of the multidisciplinary oncology care team, including physicians, nurses, pharmacists and other relevant health care professionals, have the knowledge and skills necessary to apply the new standards of care for patients with an acute leukemia.

Pages

Subscribe to RSS - Live Webinar